{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:16:52Z","timestamp":1772173012456,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1009505","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000}}],"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000020","name":"Fields Institute for Research in Mathematical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000020","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ryerson University - Faculty of Science"},{"name":"Ryerson University - Faculty of Science"},{"name":"Ryerson University - Department of Mathematics"},{"name":"Ryerson University - Department of Mathematics"},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council","doi-asserted-by":"crossref","award":["RGPIN-2018-04205"],"award-info":[{"award-number":["RGPIN-2018-04205"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>Although chemotherapy is a standard treatment for cancer, it comes with significant side effects. In particular, certain agents can induce severe muscle loss, known as cachexia, worsening patient quality of life and treatment outcomes. 5-fluorouracil, an anti-cancer agent used to treat several cancers, has been shown to cause muscle loss. Experimental data indicates a non-linear dose-dependence for muscle loss in mice treated with daily or week-day schedules. We present a mathematical model of chemotherapy-induced muscle wasting that captures this non-linear dose-dependence. Area-under-the-curve metrics are proposed to quantify the treatment\u2019s effects on lean mass and tumour control. Model simulations are used to explore alternate dosing schedules, aging effects, and morphine use in chemotherapy treatment with the aim of better protecting lean mass while actively targeting the tumour, ultimately leading to improved personalization of treatment planning and improved patient quality of life.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1009505","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T13:43:00Z","timestamp":1647870180000},"page":"e1009505","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Chemotherapy-induced cachexia and model-informed dosing to preserve lean mass in cancer treatment"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7654-8804","authenticated-orcid":true,"given":"Suzan","family":"Farhang-Sardroodi","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3536-7286","authenticated-orcid":true,"given":"Michael A.","family":"La Croix","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3226-724X","authenticated-orcid":true,"given":"Kathleen P.","family":"Wilkie","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2022,3,21]]},"reference":[{"issue":"10","key":"pcbi.1009505.ref001","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/0026-0495(95)90040-3","article-title":"Negative impact of cancer chemotherapy on protein metabolism in healthy and tumor-bearing rats","volume":"44","author":"T Le Bricon","year":"1995","journal-title":"Metabolis"},{"issue":"2","key":"pcbi.1009505.ref002","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1210\/en.2007-0828","article-title":"Ghrelin prevents cisplatin-induced mechanical hyperalgesia and cachexia","volume":"149","author":"JM Garcia","year":"2008","journal-title":"Endocrinology"},{"issue":"2","key":"pcbi.1009505.ref003","doi-asserted-by":"crossref","first-page":"7590","DOI":"10.4081\/ejtm.2018.7590","article-title":"Chemotherapy-induced muscle wasting: association with NF-\u03baB and cancer cachexia","volume":"28","author":"JS Damrauer","year":"2018","journal-title":"Eur J Transl Myol"},{"issue":"4","key":"pcbi.1009505.ref004","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","article-title":"Prognostic effect of weight loss prior to chemotherapy in cancer patients","volume":"69","author":"WD Dewys","year":"1980","journal-title":"Am J Med"},{"issue":"3","key":"pcbi.1009505.ref005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.mco.0000165004.93707.88","article-title":"Systemic inflammation, cachexia and prognosis in patients with cancer","volume":"8","author":"C Deans","year":"2005","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"6","key":"pcbi.1009505.ref006","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/PPO.0b013e3181594940","article-title":"How relevant are cytokines in colorectal cancer wasting?","volume":"13","author":"P Ravasco","year":"2007","journal-title":"Cancer J"},{"issue":"4","key":"pcbi.1009505.ref007","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/MCO.0b013e328300ecc1","article-title":"Cachexia: prevalence and impact in medicine","volume":"11","author":"BH Tan","year":"2008","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"3","key":"pcbi.1009505.ref008","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1188\/10.ONF.303-310","article-title":"Understanding weight loss in patients with colorectal cancer: a human response to illness","volume":"37","author":"SB Bapuji","year":"2010","journal-title":"Oncol Nurs Forum"},{"issue":"2","key":"pcbi.1009505.ref009","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"KC Fearon","year":"2012","journal-title":"Cell Metab"},{"issue":"11","key":"pcbi.1009505.ref010","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1172\/JCI68523","article-title":"NF-\u03baB\u2013mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia","volume":"123","author":"WA He","year":"2013","journal-title":"J Clin Invest"},{"key":"pcbi.1009505.ref011","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3389\/fphys.2016.00472","article-title":"Cancer and chemotherapy contribute to muscle loss by activating common signaling pathways","volume":"7","author":"R Barreto","year":"2016","journal-title":"Front Physiol"},{"issue":"28","key":"pcbi.1009505.ref012","doi-asserted-by":"crossref","first-page":"43442","DOI":"10.18632\/oncotarget.9779","article-title":"Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1\/2 and p38 MAPKs","volume":"7","author":"R Barreto","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"pcbi.1009505.ref013","doi-asserted-by":"crossref","first-page":"14470","DOI":"10.1038\/s41598-017-15040-1","article-title":"ACVR2B\/Fc counteracts chemotherapy-induced loss of muscle and bone mass","volume":"7","author":"R Barreto","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"pcbi.1009505.ref014","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"X Zhou","year":"2010","journal-title":"Cell"},{"issue":"1","key":"pcbi.1009505.ref015","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/jcsm.12360","article-title":"Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism","volume":"10","author":"F Pin","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"pcbi.1009505.ref016","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fphar.2013.00049","article-title":"After the chemotherapy: potential mechanisms for chemotherapy-induced delayed skeletal muscle dysfunction in survivors of acute lymphoblastic leukemia in childhood","volume":"4","author":"C Scheede-Bergdahl","year":"2013","journal-title":"Front Pharmacol"},{"issue":"4","key":"pcbi.1009505.ref017","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00280-016-3045-3","article-title":"Mitochondria: inadvertent targets in chemotherapy-induced skeletal muscle toxicity and wasting?","volume":"78","author":"JC Sorensen","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"pcbi.1009505.ref018","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MCO.0000000000000164","article-title":"Muscle wasting in cancer: the role of mitochondria","volume":"18","author":"JM Argil\u00e9s","year":"2015","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"pcbi.1009505.ref019","doi-asserted-by":"crossref","first-page":"3292087","DOI":"10.1155\/2017\/3292087","article-title":"Disrupted skeletal muscle mitochondrial dynamics, mitophagy, and biogenesis during cancer cachexia: a role for inflammation","volume":"2017","author":"BN VanderVeen","year":"2017","journal-title":"Oxid Medi Cell Longev"},{"issue":"28","key":"pcbi.1009505.ref020","doi-asserted-by":"crossref","first-page":"43442","DOI":"10.18632\/oncotarget.9779","article-title":"Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1\/2 and p38 MAPKs","volume":"7","author":"R Barreto","year":"2016","journal-title":"Oncotarget"},{"key":"pcbi.1009505.ref021","doi-asserted-by":"crossref","first-page":"7582730","DOI":"10.1155\/2018\/7582730","article-title":"Chemotherapeutic drugs and mitochondrial dysfunction: focus on doxorubicin, trastuzumab, and sunitinib","volume":"2018","author":"S Gorini","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"pcbi.1009505.ref022","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mito.2017.10.010","article-title":"Chemotherapeutic agents induce mitochondrial superoxide production and toxicity but do not alter respiration in skeletal muscle in vitro","volume":"42","author":"E Rybalka","year":"2018","journal-title":"Mitochondrion"},{"issue":"3","key":"pcbi.1009505.ref023","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/stem.590","article-title":"Mitochondrial function controls proliferation and early differentiation potential of embryonic stem cells","volume":"29","author":"S Mandal","year":"2011","journal-title":"Stem Cells"},{"issue":"10","key":"pcbi.1009505.ref024","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/nrm3877","article-title":"Mitochondrial dynamics and inheritance during cell division, development and disease","volume":"15","author":"P Mishra","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"pcbi.1009505.ref025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ceb.2017.11.003","article-title":"Mitochondrial activity in the regulation of stem cell self-renewal and differentiation","volume":"49","author":"M Khacho","year":"2017","journal-title":"Curr Opin Cell Biol"},{"issue":"8","key":"pcbi.1009505.ref026","doi-asserted-by":"crossref","first-page":"dev143420","DOI":"10.1242\/dev.143420","article-title":"The role of mitochondria in stem cell fate and aging","volume":"145","author":"H Zhang","year":"2018","journal-title":"Development"},{"key":"pcbi.1009505.ref027","doi-asserted-by":"crossref","first-page":"606639","DOI":"10.3389\/fcell.2021.606639","article-title":"Mitochondrial control of stem cell state and fate: lessons from drosophila","volume":"9","author":"SK Tiwari","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"14","key":"pcbi.1009505.ref028","doi-asserted-by":"crossref","first-page":"R551","DOI":"10.1016\/j.cub.2006.06.054","article-title":"Mitochondria: more than just a powerhouse","volume":"16","author":"HM McBride","year":"2006","journal-title":"Curr Biol"},{"issue":"4","key":"pcbi.1009505.ref029","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0092-8674(03)00116-8","article-title":"Mitochondria: releasing power for life and unleashing the machineries of death","volume":"112","author":"DD Newmeyer","year":"2003","journal-title":"Cell"},{"issue":"12","key":"pcbi.1009505.ref030","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1101\/gad.1658508","article-title":"Mitochondrial dynamics and apoptosis","volume":"22","author":"DF Suen","year":"2008","journal-title":"Genes Dev"},{"issue":"5057","key":"pcbi.1009505.ref031","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1126\/science.1533953","article-title":"Mitochondrial genetics: a paradigm for aging and degenerative diseases?","volume":"256","author":"DC Wallace","year":"1992","journal-title":"Science"},{"key":"pcbi.1009505.ref032","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.neuro.30.051606.094302","article-title":"Mitochondrial disorders in the nervous system","volume":"31","author":"S DiMauro","year":"2008","journal-title":"Annu Rev Neurosci"},{"issue":"3","key":"pcbi.1009505.ref033","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jmg.2007.054270","article-title":"Inherited mitochondrial optic neuropathies","volume":"46","author":"P Yu-Wai-Man","year":"2009","journal-title":"J Med Genet"},{"issue":"5","key":"pcbi.1009505.ref034","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.cell.2020.11.002","article-title":"Comprehensive multi-omics analysis reveals mitochondrial stress as a central biological hub for spaceflight impact","volume":"183","author":"WA da Silveira","year":"2020","journal-title":"Cell"},{"issue":"5","key":"pcbi.1009505.ref035","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"DB Longley","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"pcbi.1009505.ref036","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.3390\/jcm9072029","article-title":"Mathematical model of muscle wasting in cancer cachexia","volume":"9","author":"S Farhang-Sardroodi","year":"2020","journal-title":"J Clin Med"},{"issue":"5","key":"pcbi.1009505.ref037","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s002800100359","article-title":"Comparative study between daily and 5-days-a-week administration of oral 5-fluorouracil chemotherapy in mice: determining the superior regimen","volume":"48","author":"M Makino","year":"2001","journal-title":"Cancer Chemother Pharmacol"},{"key":"pcbi.1009505.ref038","unstructured":"Phoenix WinNonlin User\u2019s Guide; 2020. https:\/\/onlinehelp.certara.com\/phoenix\/8.3\/responsive_html5_!MasterPage!\/WinNonlin%20User%27s%20Guide.pdf."},{"issue":"3","key":"pcbi.1009505.ref039","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1158\/0008-5472.CAN-03-2524","article-title":"Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents","volume":"64","author":"M Simeoni","year":"2004","journal-title":"Cancer Res"},{"issue":"12","key":"pcbi.1009505.ref040","doi-asserted-by":"crossref","first-page":"e0143840","DOI":"10.1371\/journal.pone.0143840","article-title":"Model-based tumor growth dynamics and therapy response in a mouse model of de novo carcinogenesis","volume":"10","author":"C Loizides","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"pcbi.1009505.ref041","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1137\/141000671","article-title":"Julia: A fresh approach to numerical computing","volume":"59","author":"J Bezanson","year":"2017","journal-title":"SIAM review"},{"issue":"9","key":"pcbi.1009505.ref042","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1089\/ars.2011.3965","article-title":"Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress","volume":"15","author":"LA Gilliam","year":"2011","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"pcbi.1009505.ref043","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(13)70055-X","article-title":"Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial","volume":"14","author":"AS Dobs","year":"2013","journal-title":"Lancet Oncol"},{"issue":"2","key":"pcbi.1009505.ref044","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s12012-007-0006-4","article-title":"Anthracycline cardiotoxicity in long-term survivors of childhood cancer","volume":"7","author":"RE Scully","year":"2007","journal-title":"Cardiovasc Toxicol"},{"issue":"27","key":"pcbi.1009505.ref045","doi-asserted-by":"crossref","first-page":"6596","DOI":"10.1200\/JCO.2005.12.674","article-title":"Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls","volume":"23","author":"KL Syrjala","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3","key":"pcbi.1009505.ref046","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.critrevonc.2004.05.001","article-title":"Exercise issues in older cancer survivors","volume":"51","author":"KS Courneya","year":"2004","journal-title":"Crit Rev Oncol Hematol"},{"key":"pcbi.1009505.ref047","unstructured":"CD2F1 (CDF1) Mouse US Growth Chart; 2018. https:\/\/www.criver.com\/products-services\/find-model\/cd2f1-cdf1-mouse."},{"issue":"3","key":"pcbi.1009505.ref048","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4103\/0976-500X.136098","article-title":"Metronomic chemotherapy","volume":"5","author":"R Maiti","year":"2014","journal-title":"J Pharmacol Pharmacother"},{"issue":"3","key":"pcbi.1009505.ref049","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002800050572","article-title":"Opiate effects on 5-fluorouracil disposition in mice","volume":"39","author":"Y Li","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"key":"pcbi.1009505.ref050","doi-asserted-by":"crossref","first-page":"5483791","DOI":"10.1155\/2019\/5483791","article-title":"Metronomic chemotherapy: a systematic review of the literature and clinical experience","volume":"2019","author":"C Simsek","year":"2019","journal-title":"J Oncol"},{"key":"pcbi.1009505.ref051","doi-asserted-by":"crossref","first-page":"593468","DOI":"10.3389\/fphys.2020.593468","article-title":"The acute effects of 5 Fluorouracil on skeletal muscle resident and infiltrating immune cells in mice","volume":"11","author":"BN VanderVeen","year":"2020","journal-title":"Front Physiol"},{"issue":"2","key":"pcbi.1009505.ref052","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00280-017-3487-2","article-title":"The impact of skeletal muscle on the pharmacokinetics and toxicity of 5-fluorouracil in colorectal cancer","volume":"81","author":"GR Williams","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"issue":"8","key":"pcbi.1009505.ref053","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2174\/18715206113139990322","article-title":"Assessment of nutritional status in cancer\u2014the relationship between body composition and pharmacokinetics","volume":"13","author":"CMM Prado","year":"2013","journal-title":"Anticancer Agents Med Chem"},{"issue":"6","key":"pcbi.1009505.ref054","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00280-020-04060-w","article-title":"The gut microbiota attenuates muscle wasting by regulating energy metabolism in chemotherapy-induced malnutrition rats","volume":"85","author":"H Chen","year":"2020","journal-title":"Cancer Chemother Pharmacol"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1009505","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1009505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T15:03:36Z","timestamp":1726844616000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1009505"}},"subtitle":[],"editor":[{"given":"Feng","family":"Fu","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2022,3,21]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1009505","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.10.01.462698","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,21]]}}}